Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Immunomedics Inc (NASDAQ:IMMU)

5.73
Delayed Data
As of Apr 28
 +0.13 / +2.32%
Today’s Change
1.95
Today|||52-Week Range
7.15
+56.13%
Year-to-Date
No recent news for Immunomedics Inc.

Today’s Trading

Previous close5.60
Today’s open5.61
Day’s range5.59 - 5.80
Volume1,429,459
Average volume (3 months)3,200,103
Market cap$607.8M
Dividend yield--
Data as of 3:59pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)-21.57%
Earnings growth (this year)+2.42%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-42.81%
P/E ratioNM
Price/Sales68.00
Price/Book--

Competitors

 Today’s
change
Today’s
% change
VIVOMeridian Bioscience ...-0.20-1.33%
ALRPRBAlere Inc+3.24+0.85%
--Quidel Corp+0.29+1.35%
LNTHLantheus Holdings In...+0.15+1.17%
Data as of 4:00pm ET, 04/28/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$3.2M
Annual profit (last year)-$59.0M
Net profit margin-1,825.93%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Patent Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts